DV
Dividend Vision

TNYA — Tenaya Therapeutics Inc

Tenaya Therapeutics Inc (TNYA)

Total return is -95.3% over the past 5 years, 184.7 points behind SPY at 89.4%. Its deepest 1-year drawdown was 73.8%.

TNYA is an equity stock that focuses on the therapeutics sector. The fund does not currently pay distributions and lacks a traditional expense ratio structure typical of ETFs, suggesting it may function as a single-stock holding rather than a diversified fund. This holding appeals primarily to growth-oriented investors seeking exposure to the biopharmaceutical industry rather than income-focused investors.

TNYA key facts

Asset type
Stock
Asset class
Equity
Inception date
07/30/2021
Last close
$0.73
Market cap
$177,288,080
Average volume
1529981.0
Beta
2.837
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.44